2018
DOI: 10.1126/science.aas9315
|View full text |Cite
|
Sign up to set email alerts
|

An ingestible bacterial-electronic system to monitor gastrointestinal health

Abstract: Biomolecular monitoring in the gastrointestinal tract could offer rapid, precise disease detection and management but is impeded by access to the remote and complex environment. Here, we present an ingestible micro-bio-electronic device (IMBED) for in situ biomolecular detection based on environmentally resilient biosensor bacteria and miniaturized luminescence readout electronics that wirelessly communicate with an external device. As a proof of concept, we engineer heme-sensitive probiotic biosensors and dem… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
336
0
3

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 416 publications
(366 citation statements)
references
References 36 publications
(39 reference statements)
0
336
0
3
Order By: Relevance
“…Finally, we need to move the needle from empirically selected prebiotic and probiotic therapies to the next generation of precise mechanism-based diagnostic and therapeutic interventions. The use of genetically engineered bacterial strains to assess the gut environment, release metabolites of interest at specific locations within the GI tract, and optimize drug metabolism appears to be on the horizon 190, 191 . Rapid advances in these areas provide an optimistic outlook for microbiotabased interventions in FGIDs.…”
Section: Functional Gi Disordersmentioning
confidence: 99%
“…Finally, we need to move the needle from empirically selected prebiotic and probiotic therapies to the next generation of precise mechanism-based diagnostic and therapeutic interventions. The use of genetically engineered bacterial strains to assess the gut environment, release metabolites of interest at specific locations within the GI tract, and optimize drug metabolism appears to be on the horizon 190, 191 . Rapid advances in these areas provide an optimistic outlook for microbiotabased interventions in FGIDs.…”
Section: Functional Gi Disordersmentioning
confidence: 99%
“…On a more expansive scale, the Pediatric Research using Integrated Sensor Monitoring Systems (PRISMS) is developing both wearable and nonwearable sensors to monitor the internal and external exposome in children in their natural environment. Other groups are developing ingestible biosensors (a device that can measure chemical substances) . A thorough review of sensors has been reported elsewhere …”
Section: Future Directionsmentioning
confidence: 99%
“…Other groups are developing ingestible biosensors (a device that can measure chemical substances). (34) A thorough review of sensors has been reported elsewhere. (35)…”
Section: Future Directionsmentioning
confidence: 99%
“…[56] Aprobiotic strain of E. coli was modified to contain the following genes:asynthetic promoter that is regulated by HrtR, ah eme-responsive transcriptional repressor;C huA an outer-membrane heme transporter;a nd luxCDABE an operon that encodes all the enzymes and substrates required for photoluminescence. [56] Aprobiotic strain of E. coli was modified to contain the following genes:asynthetic promoter that is regulated by HrtR, ah eme-responsive transcriptional repressor;C huA an outer-membrane heme transporter;a nd luxCDABE an operon that encodes all the enzymes and substrates required for photoluminescence.…”
Section: Ingestible Sensors That Use Synthetic Biologymentioning
confidence: 99%